Cambodia vs Haiti: Treatment success rate for patients treated for MDR-TB
Cambodia
85.0%
in 2022
Haiti
85.0%
in 2022
Cambodia rank
35th
Haiti rank
35th
Treatment success rate for patients treated for MDR-TB over time
- Cambodia
- Haiti
How they compare
Cambodia currently reports 85.0% against 85.0% in Haiti, a difference of 0.0%.
The two have swapped places 5 times across 15 shared years of data; in 2008 it was Cambodia ahead.
Cambodia ranks 35th and Haiti ranks 35th of 163 countries.
Across the 3 decades both report, Cambodia averaged higher in 1 and Haiti in 2.
Head to head by decade
| Decade | Cambodia | Haiti | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.0% | 62.5% | 10.5% | Cambodia |
| 2010s | 75.4% | 80.2% | 4.8% | Haiti |
| 2020s | 84.3% | 85.0% | 0.7% | Haiti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Cambodia or Haiti?
- Cambodia, at 85.0% against 85.0% in Haiti as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Cambodia and Haiti?
- 0.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Haiti?
- 15 years are reported by both, from 2008 to 2022.
- How do Cambodia and Haiti rank globally for treatment success rate for patients treated for mdr-tb?
- Cambodia ranks 35th and Haiti ranks 35th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.